Terms and conditions for using Polavirexa
You already spend enough time dealing with fine print in markets, so this page keeps the rules for using the Polavirexa site as clear as possible. These terms and conditions form a legal agreement between you and Polavirexa when you access, browse, or otherwise use this site and its AI related content on liquidity, slippage, and thin markets. By continuing to use the site, you confirm that you have read, understood, and agree to follow these terms, along with our privacy policy and disclaimer. If you do not agree, you should stop using the site and avoid relying on any information or tools you find here. We may update these terms from time to time to reflect changes in our services, technology, or legal obligations, and your continued use after an update means you accept the revised version.
July 20, 2026
-
1
Scope and acceptance of terms
These terms and conditions apply to your access to and use of the Polavirexa website, including any content, examples, or tools related to AI based analysis of liquidity and slippage in thinly traded or frontier markets. They sit alongside, and should be read together with, our privacy policy and disclaimer, which explain how we handle personal information and set limits on responsibility. By using this site in any way, whether as a casual visitor or a regular user, you agree to be bound by these terms. If you are using the site on behalf of an organisation, you confirm that you are authorised to accept these terms for that organisation. -
2
Nature of the service
The content on this site, including text, graphics, logos, and any illustrative models or scenarios, is provided for general informational purposes only. It does not constitute personalised advice, a recommendation, or an offer to enter into any transaction. We may change, suspend, or withdraw parts of the site without notice, and we are under no obligation to keep all content available or up to date. You are responsible for ensuring that your use of the site complies with any laws, regulations, and internal policies that apply to you, and for deciding how, if at all, to rely on any information you find here.
-
3
Intellectual property rights
All intellectual property rights in the Polavirexa site and its content, including any proprietary methods described, are owned by us or our licensors. Subject to these terms, we grant you a limited, non exclusive, revocable licence to access and use the site for your own internal purposes. You may not copy, modify, distribute, reverse engineer, or create derivative works from the site or its content, except as permitted by applicable law or with our prior written consent. Any use of our trademarks, branding, or distinctive elements requires separate written permission. -
4
Acceptable and prohibited use
You agree not to misuse the Polavirexa site or attempt to interfere with its normal operation. This includes avoiding any attempt to gain unauthorised access to systems, bypass security controls, or disrupt other users. You must not use the site to transmit harmful code, conduct automated scraping beyond what is reasonably necessary for normal browsing, or deploy the content in ways that violate law, regulation, or third party rights. When you rely on any information from the site, you remain responsible for independent checks, and you must not present our content as if it were personalised advice from us to your clients or colleagues. -
5
Accounts, access, and security
If you choose to create an account, subscribe to updates, or submit forms, you agree to provide accurate, current information and to keep any login details confidential. You are responsible for all activities that occur under your account or through your credentials, whether performed by you or by someone else who has access. If you suspect unauthorised use, you should notify us promptly through our contact details. We reserve the right to suspend or close accounts that appear compromised, inactive for extended periods, or used in ways that breach these terms.
-
6
Privacy and data protection
Our privacy policy explains how we collect, use, and protect personal information when you visit the site or contact us. By using the site, you acknowledge that your personal data may be processed in accordance with that policy, including the use of cookies and analytics tools described there. We aim to limit data collection to what is reasonably necessary for operating the site, responding to enquiries, and understanding aggregated usage patterns, but you should review the privacy policy to understand your rights and choices. -
7
Disclaimer and no guarantees
The disclaimer on this site provides important information about the limits of our responsibility, the illustrative nature of AI based liquidity and slippage estimates, and the fact that results may vary. Past performance does not guarantee future results, especially in illiquid and frontier markets, and you should not treat any content here as a promise or prediction. By accepting these terms, you also acknowledge and agree to the disclaimer, which forms part of the overall conditions for using the site.
-
8
Limitations of liability
To the fullest extent permitted by applicable law, Polavirexa and its affiliates will not be liable for any indirect, consequential, special, or punitive damages arising out of or in connection with your use of this site, its content, or any interruption or error. We do not accept responsibility for decisions you make based on information from the site, and you remain solely accountable for verifying figures, assessing risks, and seeking independent professional advice where appropriate. If any liability cannot be excluded, it will be limited to the minimum amount required by law, and nothing in these terms is intended to expand our liability beyond that level. -
9
Indemnity and responsibility
You agree to indemnify and hold harmless Polavirexa, its affiliates, and their respective personnel from and against any claims, losses, liabilities, damages, costs, or expenses arising from your use of the site, your breach of these terms, or your violation of any law or third party right. This obligation applies to claims brought by you, your organisation, or third parties who allege that your use of the site contributed to any loss, and it operates to the extent permitted by applicable law. -
10
Governing law and jurisdiction
These terms and conditions, and any dispute or claim arising out of or relating to them or your use of the site, are governed by the laws of Canada, without giving effect to conflict of law principles that would apply the laws of another jurisdiction. Subject to any non waivable rights you may have under local law, you agree that the courts of Canada will have exclusive jurisdiction over any such dispute. We do not represent that the content on this site is appropriate or available for use in all locations, and you are responsible for ensuring that your access complies with the rules that apply to you. -
11
Changes and general provisions
We may update or revise these terms from time to time, for example to reflect changes in our services, technology, or legal obligations. When we do, we will adjust the effective date at the top of this page so you can see when the current version took effect. Your continued use of the site after any change means you accept the updated terms, so you should review this page periodically. If any provision is found to be invalid or unenforceable, the remaining provisions will continue in full force, and the invalid part will be applied as closely as possible to its original intent.
Questions about these terms
If you have questions about these terms, or how they apply to your use of the Polavirexa site and our AI focused content on liquidity and slippage, you can reach out using the contact details provided on our contact page. We may not be able to address every hypothetical scenario, but we can clarify how we intend these terms to operate in practice and how they interact with our privacy and disclaimer notices.
Email: content@polavirexa.world
Phone: +1 (%73) 748-6462
Address: 204 Saint-Sacrement Street, Montreal, QC H2Y 3S7 Canada
Effective from: July 20, 2026
Version: 1.0